Effects of stn and gpi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Moum, Sarah J ^a   Price, Catherine C ^a   Limotai, Natlada ^a,b   Oyama, Genko ^a   Ward, Herbert ^a,c   Jacobson, Charles ^a   Foote, Kelly D ^a   Okun, Michael S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BRAIN DEPTH STIMULATION; CLINICAL EVALUATION; CLINICAL FEATURE; COMPULSIVE PERSONALITY DISORDER; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE DYSREGULATION SYNDROME; FEMALE; GLOBUS PALLIDUS; HUMAN; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; REVIEW; SUBTHALAMIC NUCLEUS; THERAPY EFFECT; ARTICLE; METABOLISM; METHODOLOGY; MIDDLE AGED; REWARD;

DOPAMINE;

ADULT; DEEP BRAIN STIMULATION; DOPAMINE; FEMALE; GLOBUS PALLIDUS; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; PARKINSON DISEASE; REWARD; SUBTHALAMIC NUCLEUS;

EID: 84856264726     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029768     Document Type: Review

References (30)

1. Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, et al. (2011) Impulse control disorders in parkinson disease: A multicenter case-control study. Annals of Neurology 69: 986-996.
2. Giovannoni G, O'Sullivan J, Turner K, Manson A, Lees A, (2000) Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. Journal of Neurology, Neurosurgery & Psychiatry 68: 423-428.
3. Priebe S, (1984) Levodopa dependence: a case report. Pharmacopsychiatry 17: 109-110.
4. Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, et al. (2005) Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Movement disorders 19: 397-405.
5. Nausieda PA, (1985) Sinemet "abusers." Clinical Neuropharmacology 8: 318-327.
6. Demetriades P, Rickards H, Cavanna AE, (2011) Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: clinical aspects. Parkinsons Dis In press.
7. Knobel D, Aybek S, Pollo C, Vingerhoets FJ, Berney A, (2008) Rapid resolution of dopamine dysregulation syndrome (DDS) after subthalamic DBS for Parkinson disease (PD): a case report. Cognitive and Behavioral Neurology 21: 187-189.
8. Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, et al. (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Movement Disorders 21: 916-923.
9. Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, et al. (2007) Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Movement Disorders 22: 1623-1629.
10. Nazzaro JM, Pahwa R, Lyons KE, (2011) The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease. Parkinsonism Relat Disord In press.
11. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, et al. (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67: 589-595.
12. Cabrini S, Baratti M, Bonfà F, Cabri G, Uber E, et al. (2009) Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease. Neurol Sci In press.
13. Okun MS, Foote KD, (2010) Parkinson's disease DBS: what, when, who and why? The time has come to tailor DBS targets. Expert Review of Neurotherapeutics 10: 1847-1857.
14. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, et al. (2006) Prevalence of repetitive and reward-seeking bahviors in Parkinson disease. Neurology 67: 1254-1257.
15. Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, et al. (2009) Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet 8: 1140-1149.
16. McElroy SL, Keck PE, Pope HG, Smith JM, Strakowski SM, (1994) Compulsive buying: a report of 20 cases. Journal of Clinical Psychiatry 55: 242-248.
17. Nirenberg MJ, Waters C, (2006) Compulsive eating and weight gain related to dopamine agonist use. Movement disorders 21: 524-529.
18. Friedman JH, (1994) Punding on levodopa. Biological Psychiatry 36: 350-351.
19. Smeding HM, Goudriaan AE, Foncke EM, Schuurman PR, Speelman JD, et al. (2007) Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry 78: 517-519.
20. Hälbig TD, Tse W, Frisina PG, Baker BR, Hollander E, et al. (2009) Subthalamic deep brain stimulation and impulse control in Parkinson's disease. European Journal of Neurology 16: 493-497.
21. Avila A, Cardona X, Martín-Baranera M, Bello J, Sastre F, (2011) Impulsive and compulsive behaviors in Parkinson's disease: A one-year follow-up study. J Neurol Sci In press.
22. Oei TP, Raylu N, Casey LM, (2010) Effectiveness of group and individual formats of a combined motivational interviewing and cognitive behavioral treatment program for problem gambling: a randomized controlled trial. Behav Cogn Psychother 38: 233-238.
23. Rotondo A, Bosco D, Plastino M, Consoli A, Bosco F, (2010) Clozapine for medication-related pathological gambling in Parkinson disease. Movement disorders 25: 1994-1995.
24. Stein DJ, Grant JE, (2005) Betting on dopamine. CNS Spectrums 10: 268-270.
25. Koran LM, Bullock KD, Hartston HJ, Elliott MA, D'Andrea V, (2002) Citalopram treatment of compulsive shopping: an open-label study. J Clin Psychiatry 63: 704-708.
26. Pallanti S, Quercioli L, Sood E, Hollander E, (2002) Lithium and valproate treatment of pathological gambling: a randomized single-blind study. Journal of Clinical Psychiatry 63: 559-564.
27. Hicks CW, Pandya MM, Itin I, Fernandez HH, (2011) Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease. Parkinsonism & Related Disorders 17: 379-381.
28. Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, et al. (2006) Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Movement disorders 21: 1941-1946.
29. Bandini F, Primavera A, Pizzorno M, Cocito L, (2006) Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease. Parkinsonism & Related Disorders 13: 369-371.
30. Witjas T, Baunez C, Henry JM, Delfini M, Regis J, et al. (2005) Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation. Movement disorders 20: 1052-1055.